NCT06492590Completed
Long COVID-19 Intervention (COVIDL/MIQoL)
Assessing a Multicomponent Intervention to Improve Quality of Life in Individuals With Long COVID-19 (COVIDL/MIQoL): A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 16 Jan 2026
Brief summary (registry, in English)
The goal of this clinical trial is to assess the effectiveness of a multicomponent intervention in individuals with Long COVID. The main questions it aims to answer are: * Does the intervention increase quality of life, mental well-being, resilience, and physical condition in individuals with Long COVID? * Does the intervention decrease anxiety, depressed mood, and fatigue in individuals with Long COVID? The researchers will compare the multicomponent intervention with a control (non-intervention) group. Participants will: • Participate in a multicomponent intervention for 9 weeks (2 sessions each week, one of psycho-education and one of physical rehabilitation).
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 74 (actual)
- First submitted
- 8 Jul 2024
- Start date
- 17 Jan 2025
- Primary completion date
- 30 Sept 2025
- Lead sponsor
- Consorci Sanitari de Terrassa
- Diseases
- Long COVID and ME/CFS
- NCT number
- NCT06492590
What you commit to
- Study type: Interventional
- Participants enrolled: 74
- From 17 Jan 2025 to the primary completion date, 30 Sept 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Travel, surgery, or other event that does not allow at least 80% of the sessions
Other illness
- Physical illnesses that do not allow attendance at the sessions
- Severe mental disorders that make participation in groups inadvisable
Other
- Severe sensory deficits
- No comprehension of the language
Who the study is looking for
- Individuals diagnosed with Long COVID-19
- Present discomfort with the situation
- Individuals aged 18 to 75
- Sign the informed consent form
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Consorci Sanitari de Terrassa Coordinator of this site? Confirm its status | Terrassa | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.